Clinical Trials
3 trialsNCT02650986 2025-06-17
Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1
Roswell Park Cancer Institute
Phase 1/2 Active not recruiting
NCT00005617 2020-08-03
Vaccine Therapy in Treating Patients With Stage IV or Relapsed Malignant Melanoma
Jonsson Comprehensive Cancer Center
Phase 1 Completed
NCT01783431 2015-10-02
Study of Vaccination With Poly-ICLC and Peptide-pulsed Dendritic Cells
Medical University of South Carolina
Phase 1 Terminated